Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China.
Revenue is primarily driven by Cord Blood Processing Fees (58.1%) and Cord Blood Storage Fees (40.9%).
Most recently: Current Report on Form 6-K (2026-03-03).
—
Market Cap
—
Revenue
—
Net Income
Revenue by Segment